Reported Sunday, Mesoblast Completes Patient Treatment In Pivotal Phase 3 MSB-DR004 Trial Of Rexlemestrocel-L For Chronic Low Back Pain, Enrolling 350 Patients

뉴스 본문을 불러오고 있어요.

Reported Sunday, Mesoblast Completes Patient Treatment In Pivotal Phase 3 MSB-DR004 Trial Of Rexlemestrocel-L For Chronic Low Back Pain, Enrolling 350 Patients | 웨이프 WAPE

Reported Sunday, Mesoblast Completes Patient Treatment In Pivotal Phase 3 MSB-DR004 Trial Of Rexlemestrocel-L For Chronic Low Back Pain, Enrolling 350 Patients

기사 요약

관련 종목

댓글 —